Application of biomaterials in treating early osteonecrosis of the femoral head: Research progress and future perspectives
- PMID: 37080444
- DOI: 10.1016/j.actbio.2023.04.005
Application of biomaterials in treating early osteonecrosis of the femoral head: Research progress and future perspectives
Abstract
Osteonecrosis of the femoral head (ONFH), a progressive pathological process of femoral head ischemia and osteocyte necrosis, is a refractory orthopedic disease caused by multiple etiologies and there is no complete cure at present. With the extension of ONFH duration, osteocyte apoptosis and trabecular bone loss can decrease the load-bearing capacity of the femoral head, which leads to the collapse of the articular cartilage and subchondral bone. Therefore, an urgent clinical need exists to develop effective treatment strategies of early-stage ONFH for maintaining the hip joint function and preventing femoral head collapse. In recent years, extensive attention has been paid to the application of diverse biomaterials in treating early ONFH for sustaining the normal morphology and function of the autologous femoral head, and slowing disease progression. Herein, we review the research progress of bone grafts, metallic materials, bioceramics, bioglasses and polymer materials for early ONFH treatment, and discuss the biological mechanisms of bone repair and regeneration in the femoral-head necrotic area. We propose suggestions for future research directions, from a special perspective of improving the local microenvironment in femoral head by facilitating vessel-associated osteoclasts (VAOs) generation and coupling of bone-specific angiogenesis and osteogenesis, as well as inhibiting bone-associated osteoclasts (BAOs) and BAO-mediated bone resorption. This review can provide ideas for the research, development, and clinical application of biomaterials for treating early ONFH. STATEMENT OF SIGNIFICANCE: We believe that at least three aspects of this manuscript make it interesting to readers of the Acta Biomaterialia. First, we briefly summarize the incidence, pathogenesis, risk factors, classification criteria and treatment of early osteonecrosis of the femoral head (ONFH). Second, we review the research progress in biomaterials for early ONFH treatment and the biological mechanisms of bone repair and regeneration in femoral-head necrotic area. Third, we propose future research progress on improving the local microenvironment in femoral head by facilitating vessel-associated osteoclasts generation and coupling of bone-specific angiogenesis and osteogenesis, as well as inhibiting bone-associated osteoclasts and bone resorption. We hope this review can provide ideas for the research, development, and clinical application of biomaterials for treating early ONFH.
Keywords: Angiogenesis; Biomaterials; Bone resorption; Early osteonecrosis of the femoral head; Osteogenesis.
Copyright © 2023 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
An injectable hydrogel loaded with miRNA nanocarriers promotes vessel-associated osteoclast (VAO)-mediated angiogenesis and bone regeneration in osteonecrosis of the rat femoral head.Biomaterials. 2025 Sep;320:123252. doi: 10.1016/j.biomaterials.2025.123252. Epub 2025 Mar 10. Biomaterials. 2025. PMID: 40081225
-
Key pathway to prevent the collapse of femoral head in osteonecrosis.Eur Rev Med Pharmacol Sci. 2015 Aug;19(15):2766-74. Eur Rev Med Pharmacol Sci. 2015. PMID: 26241528
-
The Use of Platelet-Rich Plasma for the Treatment of Osteonecrosis of the Femoral Head: A Systematic Review.Biomed Res Int. 2020 Mar 7;2020:2642439. doi: 10.1155/2020/2642439. eCollection 2020. Biomed Res Int. 2020. PMID: 32219128 Free PMC article.
-
Subchondral fracture begins from the bone resorption area in osteonecrosis of the femoral head: a micro-computerised tomography study.Int Orthop. 2018 Jul;42(7):1479-1484. doi: 10.1007/s00264-018-3879-x. Epub 2018 Mar 14. Int Orthop. 2018. PMID: 29541811
-
A Mini Review: Stem Cell Therapy for Osteonecrosis of the Femoral Head and Pharmacological Aspects.Curr Pharm Des. 2019;25(10):1099-1104. doi: 10.2174/1381612825666190527092948. Curr Pharm Des. 2019. PMID: 31131747 Review.
Cited by
-
Relieving oxidative stress microenvironment and promoting vascularized bone formation to treat femoral head necrosis using 3D-printed scaffold with ultralong-term multienzyme-like activity.J Orthop Translat. 2025 Jun 28;53:206-220. doi: 10.1016/j.jot.2025.06.010. eCollection 2025 Jul. J Orthop Translat. 2025. PMID: 40678611 Free PMC article.
-
Three-dimensional distribution of subchondral fracture lines in osteonecrosis of the femoral head.J Orthop Translat. 2024 Jun 20;47:97-104. doi: 10.1016/j.jot.2024.06.004. eCollection 2024 Jul. J Orthop Translat. 2024. PMID: 39659662 Free PMC article.
-
M2 macrophages-derived exosomes for osteonecrosis of femoral head treatment: modulating neutrophil extracellular traps formation and endothelial phenotype transition.Bone Res. 2025 Apr 1;13(1):42. doi: 10.1038/s41413-025-00412-5. Bone Res. 2025. PMID: 40169566 Free PMC article.
-
Enhanced osteogenic and angiogenic capabilities of adipose-derived stem cells in fish collagen scaffolds for treatment of femoral head osteonecrosis.Sci Rep. 2025 May 26;15(1):18300. doi: 10.1038/s41598-025-03015-6. Sci Rep. 2025. PMID: 40419685 Free PMC article.
-
Subchondral osteoclasts and osteoarthritis: new insights and potential therapeutic avenues.Acta Biochim Biophys Sin (Shanghai). 2024 Apr 25;56(4):499-512. doi: 10.3724/abbs.2024017. Acta Biochim Biophys Sin (Shanghai). 2024. PMID: 38439665 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials